Ohr Pharmaceutical Announces Efficacy Results from the MAKO Study in Wet-AMD
January 05, 2018 06:00 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported topline...
Ohr Pharmaceutical Reports Fiscal Year 2017 Financial Results
December 15, 2017 07:00 ET
|
Ohr Pharmaceutical, Inc.
Management to Host a Conference Call and Webcast at 8:30 a.m. Eastern Time Today NEW YORK, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical...
Ohr Pharmaceutical to Announce Fiscal Fourth Quarter & Year End 2017 Results on Friday, December 15
December 12, 2017 08:00 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that...
Ohr Pharmaceutical to Present at the Dawson James 3rd Annual Small Cap Growth Conference
October 11, 2017 08:00 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that...
Ohr Pharmaceutical Announces Fiscal Third Quarter 2017 Earnings
August 08, 2017 16:01 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported...
Ohr Pharmaceutical to Announce Fiscal Third Quarter 2017 Results on August 8
July 31, 2017 08:00 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, July 31, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that...
Ohr Pharmaceutical to Present at the 2017 Marcum Microcap Conference
June 12, 2017 08:00 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, June 12, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that...
Ohr Pharmaceutical Announces Appointment of Hon. Mike Ferguson as Chairman of the Board of Directors
May 11, 2017 16:15 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, May 11, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced the...
Ohr Pharmaceutical Announces Fiscal Second Quarter 2017 Earnings
May 11, 2017 16:01 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, May 11, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported results...
Ohr Pharmaceutical to Announce Fiscal Second Quarter 2017 Results on May 11
May 09, 2017 08:00 ET
|
Ohr Pharmaceutical, Inc.
NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that it...